Potent neuronal nicotinic ACh receptor agonist (EC50
values are 1.8, 5, 9 and 23 nM for α
4 and α
4 receptors respectively). Improves cognitive function in a MPTP-induced model of Parkinson's Disease in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.
Cosford et al.
Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
Schneider et al.